Epidemiologic trends in neuroendocrine tumors: An examination of incidence rates and survival of specific patient subgroups over the past 20 years
Open Access
- 1 August 2018
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 45 (4) , 249-258
Abstract
No abstract availableKeywords
Funding Information
- Conquer Cancer Foundation
- American Society of Clinical Oncology
- National Institutes of Health
This publication has 23 references indexed in Scilit:
- Abdominal imaging utilization in the emergency department: trends over two decadesInternational Journal of Emergency Medicine, 2011
- Everolimus for Advanced Pancreatic Neuroendocrine TumorsNew England Journal of Medicine, 2011
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine TumorsNew England Journal of Medicine, 2011
- Improving Survival for Stage IV Non-small Cell Lung Cancer: A Surveillance, Epidemiology, and End Results Survey from 1990 to 2005Journal of Thoracic Oncology, 2009
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United StatesJournal of Clinical Oncology, 2008
- TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading systemVirchows Archiv, 2006
- The Will Rogers PhenomenonNew England Journal of Medicine, 1985
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Tests for Linear Trends in Proportions and Frequencies1955
- Some Methods for Strengthening the Common χ 2 TestsBiometrics, 1954